Canada markets close in 2 hours 54 minutes

Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
24.39+0.42 (+1.75%)
At close: 03:00PM CST
Currency in CNY

Valuation Measures4

Market Cap (intraday) 13.59B
Enterprise Value 12.10B
Trailing P/E 22.09
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)3.95
Price/Book (mrq)4.63
Enterprise Value/Revenue 3.53
Enterprise Value/EBITDA 17.25

Trading Information

Stock Price History

Beta (5Y Monthly) 0.31
52-Week Change 351.04%
S&P500 52-Week Change 324.96%
52 Week High 326.89
52 Week Low 314.30
50-Day Moving Average 324.74
200-Day Moving Average 319.75

Share Statistics

Avg Vol (3 month) 38.49M
Avg Vol (10 day) 36.94M
Shares Outstanding 5567.14M
Implied Shares Outstanding 6567.14M
Float 8431.13M
% Held by Insiders 122.87%
% Held by Institutions 121.96%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.8
Forward Annual Dividend Yield 43.34%
Trailing Annual Dividend Rate 30.80
Trailing Annual Dividend Yield 33.34%
5 Year Average Dividend Yield 43.03
Payout Ratio 455.30%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 20, 2024
Last Split Factor 215:10
Last Split Date 3Jul 02, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 17.90%
Operating Margin (ttm)21.69%

Management Effectiveness

Return on Assets (ttm)8.31%
Return on Equity (ttm)21.75%

Income Statement

Revenue (ttm)3.43B
Revenue Per Share (ttm)6.10
Quarterly Revenue Growth (yoy)15.30%
Gross Profit (ttm)N/A
EBITDA 705.86M
Net Income Avi to Common (ttm)614.24M
Diluted EPS (ttm)1.09
Quarterly Earnings Growth (yoy)32.00%

Balance Sheet

Total Cash (mrq)1.71B
Total Cash Per Share (mrq)3.06
Total Debt (mrq)36.25M
Total Debt/Equity (mrq)1.23%
Current Ratio (mrq)1.49
Book Value Per Share (mrq)5.24

Cash Flow Statement

Operating Cash Flow (ttm)776.81M
Levered Free Cash Flow (ttm)727.93M